About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Ophthalmology
›
top-articles
Department of Ophthalmology
816
(top 1%)
papers
30.8K
(top 1%)
citations
85
(top 0.1%)
h
-index
138
(top 1%)
g
-index
838
all documents
32.2K
doc citations
3.1K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Treatment of Leber Congenital Amaurosis Due to
RPE65
Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
Human Gene Therapy
2008
880
2
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Proceedings of the National Academy of Sciences of the United States of America
2008
639
3
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
Nature
2011
573
4
DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88
Cell
2012
526
5
Arrangement of rhodopsin transmembrane α-helices
Nature
1997
486
6
Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement
Proceedings of the National Academy of Sciences of the United States of America
2013
401
7
High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
Molecular Therapy
2009
355
8
Long-term Morphologic Effects of Antiglaucoma Drugs on the Conjunctiva and Tenon's Capsule in Glaucomatous Patients
Ophthalmology
1989
337
9
Improvement and Decline in Vision with Gene Therapy in Childhood Blindness
New England Journal of Medicine
2015
333
10
Rhodopsin and phototransduction: a model system for G protein‐linked receptors
FASEB Journal
1992
310
11
Human
RPE65
Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year
Human Gene Therapy
2009
305
12
Normative Data for Macular Thickness by High-Definition Spectral-Domain Optical Coherence Tomography (Spectralis)
American Journal of Ophthalmology
2009
274
13
Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis
Ophthalmology
1998
247
14
A Comprehensive Review of Retinal Gene Therapy
Molecular Therapy
2013
245
15
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in
db/db
Mice
Diabetes
2018
243
16
Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death
Proceedings of the National Academy of Sciences of the United States of America
2013
239
17
Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa
Proceedings of the National Academy of Sciences of the United States of America
2012
237
18
Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina
Molecular Therapy
2011
234
19
Anti-rhodopsin monoclonal antibodies of defined specificity: Characterization and application
Vision Research
1991
225
20
Safety of Recombinant Adeno-Associated Virus Type 2–RPE65 Vector Delivered by Ocular Subretinal Injection
Molecular Therapy
2006
196
21
Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial
Human Genetics
2016
195
22
Late endophthalmitis associated with glaucoma drainage implants
Ophthalmology
2001
189
23
Rhodopsin structure, function, and topography the Friedenwald lecture
Investigative Ophthalmology and Visual Science
2001
189
24
Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor
Diabetologia
1993
185
25
Phosphorylation sites in bovine rhodopsin
Biochemistry
1993
185
26
Gene Therapy Restores Vision-Dependent Behavior as Well as Retinal Structure and Function in a Mouse Model of RPE65 Leber Congenital Amaurosis
Molecular Therapy
2006
185
27
Pharmacological Chaperone-mediated in Vivo Folding and Stabilization of the P23H-opsin Mutant Associated with Autosomal Dominant Retinitis Pigmentosa
Journal of Biological Chemistry
2003
183
28
Interaction of rhodopsin with the G-protein, transducin
BioEssays
1993
181
29
Endothelial Damage Associated with Intraocular Lenses
American Journal of Ophthalmology
1976
173
30
Glaucoma’s impact on quality of life and its relation to clinical indicators
Ophthalmology
1998
168
31
Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps
Translational Vision Science and Technology
2018
168
32
Prolonged Recovery of Retinal Structure/Function after Gene Therapy in an Rs1h-Deficient Mouse Model of X-Linked Juvenile Retinoschisis
Molecular Therapy
2005
166
33
Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model
Proceedings of the National Academy of Sciences of the United States of America
2019
162
34
Clinical and Microbiological Characteristics of Fungal Keratitis in the United States, 2001–2007: A Multicenter Study
Ophthalmology
2011
161
35
Cytotoxicity of Ophthalmic Preservatives
American Journal of Ophthalmology
1974
160
36
Endothelial dysfunction as a potential contributor in diabetic nephropathy
Nature Reviews Nephrology
2011
159
37
Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA)
Molecular Vision
2005
159
38
Central Cornea Guttata
American Journal of Ophthalmology
1967
153
39
Mitochondrial oxidative stress in the retinal pigment epithelium (RPE) led to metabolic dysfunction in both the RPE and retinal photoreceptors
Redox Biology
2019
146
40
Treatment of Paraneoplastic Visual Loss With Intravenous Immunoglobulin
JAMA Ophthalmology
1999
144
41
Retinoids Assist the Cellular Folding of the Autosomal Dominant Retinitis Pigmentosa Opsin Mutant P23H
Journal of Biological Chemistry
2004
144
42
ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy
Molecular Therapy
2012
143
43
Safety in Nonhuman Primates of Ocular AAV2-RPE65, a Candidate Treatment for Blindness in Leber Congenital Amaurosis
Human Gene Therapy
2006
142
44
Effects of Intraoperative 5-Fluorouracil or Mitomycin C on Glaucoma Filtration Surgery in the Rabbit
Ophthalmology
1993
141
45
Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa
American Journal of Ophthalmology
1999
140
46
Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential
Molecular Vision
2008
140
47
Ophthalmic Manifestations of Rochalimaea Species
American Journal of Ophthalmology
1994
139
48
Stereoscopic Perception and Snellen Visual Acuity
American Journal of Ophthalmology
1974
135
49
Long-term Retinal Function and Structure Rescue Using Capsid Mutant AAV8 Vector in the rd10 Mouse, a Model of Recessive Retinitis Pigmentosa
Molecular Therapy
2011
135
50
Rhodopsin kinase: substrate specificity and factors that influence activity
Biochemistry
1988
129
site/software ©
exaly
; All materials licenced under
CC by-SA
.